Insider · CIK 0001656125

Francois Eric

Reports to the SEC for 4 companies · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001656125

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-04	CEROCERO THERAPEUTICS HOLDINGS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1.82M sh	—	—	1,823,278
2021-07-01	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+83.3K sh	—	—	83,300
2021-07-01	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+83.3K sh	—	—	83,300
2021-07-01	CRVOCervoMed Inc. · Restricted Stock UnitA Award	Director	AAward	+69.4K sh	—	—	69,400
2021-01-29	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2020-12-21	SCYXSCYNEXIS INCP Purchase	Chief Financial Officer	PPurchase	+600 sh	$6.25	+$3,750	11,732
2020-12-21	SCYXSCYNEXIS INC · Common Stock WarrantA Award	Chief Financial Officer	AAward	+300 sh	—	—	300
2020-12-21	SCYXSCYNEXIS INC · Common Stock WarrantA Award	Chief Financial Officer	AAward	+300 sh	—	—	300
2020-11-25	SCYXSCYNEXIS INCF Tax Payment	Chief Financial Officer	FTax Payment	−3,480 sh	$6.81	−$23.7K	11,132
2020-02-15	SCYXSCYNEXIS INCF Tax Payment	Chief Financial Officer	FTax Payment	−979 sh	$9.80	−$9,594.2	14,412
2020-01-31	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+375K sh	—	—	375,000
2019-02-15	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2019-02-15	SCYXSCYNEXIS INCA Award	Chief Financial Officer	AAward	+125K sh	—	—	149,917
2018-03-08	SCYXSCYNEXIS INC · Common Stock Warrant (right to buy)P Purchase	Chief Financial Officer	PPurchase	+2,662 sh	—	—	2,662
2018-03-08	SCYXSCYNEXIS INC · Common Stock Warrant (right to buy)P Purchase	Chief Financial Officer	PPurchase	+4,437 sh	—	—	4,437
2018-03-08	SCYXSCYNEXIS INCP Purchase	Chief Financial Officer	PPurchase	+5,917 sh	$1.69	+$9,999.73	24,917
2018-02-09	SCYXSCYNEXIS INC · Stock option (right to buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2017-01-31	SCYXSCYNEXIS INC · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2016-06-24	SCYXSCYNEXIS INC · Common Stock Warrant (right to buy)P Purchase	Chief Financial Officer	PPurchase	+6,750 sh	$0.02	+$135	6,750
2016-06-24	SCYXSCYNEXIS INCP Purchase	Chief Financial Officer	PPurchase	+15K sh	$2.39	+$35.9K	15,000
2016-04-01	SCYXSCYNEXIS INC · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2015-11-02	SCYXSCYNEXIS INC · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Apr 214
Francois Eric0001213900-26-046329
SEC(opens sec.gov)
Jul 64
Francois Eric0001437749-21-016509
SEC(opens sec.gov)
Feb 24
Francois Eric0001209191-21-006716
SEC(opens sec.gov)
Dec 234
Francois Eric0001209191-20-064955
SEC(opens sec.gov)
Dec 44
Francois Eric0001209191-20-061878
SEC(opens sec.gov)
Feb 44
Francois Eric0001209191-20-006273
SEC(opens sec.gov)
Feb 194
Francois Eric0001209191-19-011127
SEC(opens sec.gov)
Mar 124
Francois Eric0001209191-18-018707
SEC(opens sec.gov)
Feb 134
Francois Eric0001209191-18-009633
SEC(opens sec.gov)
Feb 24
SCYNEXIS INC0001628280-17-000756
SEC(opens sec.gov)
Jun 284
SCYNEXIS INC0001628280-16-017406
SEC(opens sec.gov)

Companies

Address

C/O 60 DEGREES PHARMACEUTICALS, INC. 1025 CONNECTICUT AVENUE NW SUITE 1000

WASHINGTON, DC, 20036